Skip to main content

Effect of Fasting-Mimicking Diet or Continuous Energy Restriction on Weight Loss, Body Composition, and Appetite-Regulating Hormones Among Metabolically Healthy Women with Obesity: a Randomized Controlled, Parallel Trial

Abstract

Background

Fasting-mimicking diet (FMD) has been recently promoted to achieve similar metabolic changes of fasting. The purpose of our study was to compare the effect of FMD versus continuous energy restriction (CER) on anthropometric measurements, body composition, glucose metabolism, and serum levels of leptin, neuropeptide Y (NPY), and total ghrelin.

Methods

A randomized controlled trial (RCT) was conducted on 60 women with obesity aged 18–55 years. Subjects received either a 5-day FMD (low in energy, sugars, and proteins, but high in unsaturated fats) or a CER (an average daily energy deficit of 500 kcal) for 2 months. Anthropometric and biochemical factors were measured at baseline and the end of the study. Serum levels of leptin, total ghrelin, and NPY were tested with an ELISA kit. Physical activity and dietary intakes were also recorded.

Results

There was no significant difference in weight loss between the two groups: mean weight change for CER was − 2.29 (standard deviation [SD], 1.95) kg compared to − 1.13 (2.27) kg for FMD (p = 0.06). There was more reduction in the basal metabolic rate (BMR) in the CER group (p = 0.045). Favorable effects on fat mass and muscle mass were only seen in the FMD group. Although insulin resistance was reduced in the FMD group compared to the CER group, results were not significant after adjustment. After controlling for potential confounders, there was a significant increase in serum levels of total ghrelin (p = 0.048) and NPY (p = 0.041) following CER; however, results for circulating leptin were not statistically significant (p = 0.48).

Conclusions

There was no significant difference in weight loss following FMD and CER. However, FMD was more effective at reducing insulin resistance and regulating appetite-regulating hormones as well as preserving muscle mass and BMR.

Trial Registration

This trial was registered at the Iranian Clinical Trial Registry (https://www.irct.ir/trial/40881) with the IRCT identification number IRCT20190717044244N1.

This is a preview of subscription content, access via your institution.

Fig. 1

Data Availability

Because of ethical restrictions on sharing a de-identified dataset (data contain potentially identifying or sensitive patient information), data from this study are available upon request. These restrictions were imposed by the Ethics Committee and principal investigator.

References

  1. Jiang L, Rong J, Wang Y, et al. The relationship between body mass index and hip osteoarthritis: a systematic review and meta-analysis. Joint Bone Spine. 2011;78(2):150–5.

    Article  PubMed  Google Scholar 

  2. Lauby-Secretan B, Scoccianti C, Loomis D, et al. Body fatness and cancer--viewpoint of the IARC Working Group. N Engl J Med. 2016;375(8):794–8.

    Article  PubMed  PubMed Central  Google Scholar 

  3. Singh GM, Danaei G, Farzadfar F, et al. The age-specific quantitative effects of metabolic risk factors on cardiovascular diseases and diabetes: a pooled analysis. PLoS One. 2013;8(7):e65174.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  4. Finucane MM, Stevens GA, Cowan MJ, et al. National, regional, and global trends in body-mass index since 1980: systematic analysis of health examination surveys and epidemiological studies with 960 country-years and 9.1 million participants. Lancet. 2011;377(9765):557–67.

    Article  PubMed  PubMed Central  Google Scholar 

  5. Afshin A, Forouzanfar MH, Reitsma MB, et al. Health effects of overweight and obesity in 195 countries over 25 years. N Engl J Med. 2017;377(1):13–27.

    Article  PubMed  Google Scholar 

  6. Colagiuri S, Lee CM, Colagiuri R, et al. The cost of overweight and obesity in Australia. Med J Aust. 2010;192(5):260–4.

    Article  PubMed  Google Scholar 

  7. Deighton K, Batterham RL, Stensel DJ. Appetite and gut peptide responses to exercise and calorie restriction. The effect of modest energy deficits. Appetite. 2014;81:52–9.

    Article  PubMed  Google Scholar 

  8. Lean MEJ, Malkova D. Altered gut and adipose tissue hormones in overweight and obese individuals: cause or consequence? Int J Obes. 2016;40(4):622–32.

    Article  CAS  Google Scholar 

  9. Greenway FL. Physiological adaptations to weight loss and factors favouring weight regain. Int J Obes. 2015;39(8):1188–96.

    Article  CAS  Google Scholar 

  10. Dansinger ML, Gleason JA, Griffith JL, et al. Comparison of the Atkins, Ornish, Weight Watchers, and Zone diets for weight loss and heart disease risk reduction: a randomized trial. JAMA. 2005;293(1):43–53.

    Article  CAS  PubMed  Google Scholar 

  11. Miller SL, Wolfe RR. The danger of weight loss in the elderly. J Nutr Health Aging. 2008;12(7):487–91.

    Article  CAS  PubMed  Google Scholar 

  12. Harvie M, Howell A. Potential benefits and harms of intermittent energy restriction and intermittent fasting amongst obese, overweight and normal weight subjects-a narrative review of human and animal evidence. Behav Sci (Basel). 2017;7(1)

  13. Ash S, Reeves MM, Yeo S, et al. Effect of intensive dietetic interventions on weight and glycaemic control in overweight men with type II diabetes: a randomised trial. Int J Obes Relat Metab Disord. 2003;27(7):797–802.

    Article  CAS  PubMed  Google Scholar 

  14. Catenacci VA, Pan Z, Ostendorf D, et al. A randomized pilot study comparing zero-calorie alternate-day fasting to daily caloric restriction in adults with obesity. Obesity. 2016;24(9):1874–83.

    Article  CAS  PubMed  Google Scholar 

  15. Zuo L, He F, Tinsley GM, et al. Comparison of high-protein, intermittent fasting low-calorie diet and heart healthy diet for vascular health of the obese. Front Physiol. 2016;7:350.

    Article  PubMed  PubMed Central  Google Scholar 

  16. Byrne NM, Sainsbury A, King NA, et al. Intermittent energy restriction improves weight loss efficiency in obese men: the MATADOR study. Int J Obes. 2018;42(2):129–38.

    Article  CAS  Google Scholar 

  17. Heilbronn LK, Smith SR, Martin CK, et al. Alternate-day fasting in nonobese subjects: effects on body weight, body composition, and energy metabolism. Am J Clin Nutr. 2005;81(1):69–73.

    Article  CAS  PubMed  Google Scholar 

  18. Seimon RV, Roekenes JA, Zibellini J, et al. Do intermittent diets provide physiological benefits over continuous diets for weight loss? A systematic review of clinical trials. Mol Cell Endocrinol. 2015;418:153–72.

    Article  CAS  PubMed  Google Scholar 

  19. Harvie M, Wright C, Pegington M, et al. The effect of intermittent energy and carbohydrate restriction v. daily energy restriction on weight loss and metabolic disease risk markers in overweight women. Br J Nutr. 2013;110(8):1534–47.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  20. Trepanowski JF, Kroeger CM, Barnosky A, et al. Effects of alternate-day fasting or daily calorie restriction on body composition, fat distribution, and circulating adipokines: secondary analysis of a randomized controlled trial. Clin Nutr. 2018;37(6 Pt A):1871–8.

    Article  CAS  PubMed  Google Scholar 

  21. Harvie MN, Pegington M, Mattson MP, et al. The effects of intermittent or continuous energy restriction on weight loss and metabolic disease risk markers: a randomized trial in young overweight women. Int J Obes. 2011;35(5):714–27.

    Article  CAS  Google Scholar 

  22. Brandhorst S, Choi IY, Wei M, et al. A periodic diet that mimics fasting promotes multi-system regeneration, enhanced cognitive performance, and healthspan. Cell Metab. 2015;22(1):86–99.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  23. Wei M, Brandhorst S, Shelehchi M, et al. Fasting-mimicking diet and markers/risk factors for aging, diabetes, cancer, and cardiovascular disease. Sci Transl Med. 2017;9(377)

  24. Ainsworth BE, Haskell WL, Herrmann SD, et al. 2011 Compendium of physical activities: a second update of codes and MET values. Med Sci Sports Exerc. 2011;43(8):1575–81.

    Article  PubMed  Google Scholar 

  25. National Heart L, Blood Institute %J Washington D, USA: United States Department of Health, Services H. NIH Publication No. 98–4083. 1998.

  26. Lupton JR, Brooks J, Butte N, et al. Dietary reference intakes for energy, carbohydrate, fiber, fat, fatty acids, cholesterol, protein, and amino acids. 2002;5:589–768.

  27. Roubenoff R. Applications of bioelectrical impedance analysis for body composition to epidemiologic studies. Am J Clin Nutr. 1996;64(3 Suppl):459s–62s.

    Article  CAS  PubMed  Google Scholar 

  28. Song Y, Manson JE, Tinker L, et al. Insulin sensitivity and insulin secretion determined by homeostasis model assessment and risk of diabetes in a multiethnic cohort of women: the Women’s Health Initiative Observational Study. Diabetes Care. 2007;30(7):1747–52.

    Article  PubMed  Google Scholar 

  29. Katz A, Nambi SS, Mather K, et al. Quantitative insulin sensitivity check index: a simple, accurate method for assessing insulin sensitivity in humans. J Clin Endocrinol Metab. 2000;85(7):2402–10.

    Article  CAS  PubMed  Google Scholar 

  30. Matthews DR, Hosker JP, Rudenski AS, et al. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia. 1985;28(7):412–9.

    Article  CAS  PubMed  Google Scholar 

  31. Suresh K, Chandrashekara S. Sample size estimation and power analysis for clinical research studies. J Hum Reprod Sci. 2012;5(1):7–13.

    Article  PubMed  PubMed Central  Google Scholar 

  32. Gupta SK. Intention-to-treat concept: a review. Perspect Clin Res. 2011;2(3):109–12.

    Article  PubMed  PubMed Central  Google Scholar 

  33. Wei S, Han R, Zhao J, et al. Intermittent administration of a fasting-mimicking diet intervenes in diabetes progression, restores β cells and reconstructs gut microbiota in mice. Nutr Metab. 2018;15(1):80.

    Article  CAS  Google Scholar 

  34. Hardy OT, Czech MP, Corvera S. What causes the insulin resistance underlying obesity? Curr Opin Endocrinol Diabetes Obes. 2012;19(2):81.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  35. Kassab SE, Maklady,FAJSCUMJ. Changes in serum leptin concentrations during Ramadan fasting in lean and obese individuals. 2000;3(1):83–91.

  36. Dubuc GR, Phinney SD, Stern JS, et al. Changes of serum leptin and endocrine and metabolic parameters after 7 days of energy restriction in men and women. Metabolism. 1998;47(4):429–34.

    Article  CAS  PubMed  Google Scholar 

  37. Lamošová D, Máčajová M, Zeman MJAVB. Effects of short-term fasting on selected physiological functions in adult male and female Japanese quail. 2004;73(1):9–16.

  38. Murphy K, Bloom S. Gut hormones in the control of appetite. Exp Phsysiol. 2004;89(5):507–16.

    Article  CAS  Google Scholar 

  39. Havel PJ, Kasim-Karakas S, Mueller W, et al. Relationship of plasma leptin to plasma insulin and adiposity in normal weight and overweight women: effects of dietary fat content and sustained weight loss. J Clin Endocrinol Metab. 1996;81(12):4406–13.

    CAS  PubMed  Google Scholar 

  40. Wren AM, Small CJ, Abbott CR, et al. Ghrelin causes hyperphagia and obesity in rats. 2001;50(11):2540–7.

  41. Wren A, Seal L, Cohen M, Brynes A, Frost G, Murphy K, et al. Ghrelin enhances appetite and increases food intake in humans. 2001.

  42. Asakawa A, Inui A, Kaga O, et al. Ghrelin is an appetite-stimulatory signal from stomach with structural resemblance to motilin. 2001;120(2):337–45.

  43. Tschöp M, Smiley DL, Heiman ML. Ghrelin induces adiposity in rodents. Nature. 2000;407(6806):908–13.

    Article  PubMed  Google Scholar 

  44. Cummings DE, Shannon MH. Roles for ghrelin in the regulation of appetite and body weight. Arch Surg. 2003;138(4):389–96.

    Article  CAS  PubMed  Google Scholar 

  45. Clark JT, Kalra PS, Crowley WR, et al. Neuropeptide Y and human pancreatic polypeptide stimulate feeding behavior in rats. Endocrinology. 1984;115(1):427–9.

    Article  CAS  PubMed  Google Scholar 

  46. Morley J, Levine A, Gosnell B, et al. Effect of neuropeptide Y on ingestive behaviors in the rat. Am J Phys Regul Integr Comp Phys. 1987;252(3):R599–609.

    CAS  Google Scholar 

  47. Stanley BG, Kyrkouli SE, Lampert S, et al. Neuropeptide Y chronically injected into the hypothalamus: a powerful neurochemical inducer of hyperphagia and obesity. Peptides. 1986;7(6):1189–92.

    Article  CAS  PubMed  Google Scholar 

  48. Kalra SP, Dube MG, Sahu A, et al. Neuropeptide Y secretion increases in the paraventricular nucleus in association with increased appetite for food. Proc Natl Acad Sci U S A. 1991;88(23):10931–5.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  49. Patel HR, Qi Y, Hawkins EJ, et al. Neuropeptide Y deficiency attenuates responses to fasting and high-fat diet in obesity-prone mice. 2006;55(11):3091–8.

  50. Khoshdel A, Kheiri S, Nasiri J, Heidarian EJMjotIRoI. The effect of Ramadan fasting on serum leptin, neuropeptide Y and insulin in pregnant women. 2014;28:92.

  51. Shi H, Clegg DJ. Sex differences in the regulation of body weight. Physiol Behav. 2009;97(2):199–204.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  52. Nicklas BJ, Katzel LI, Ryan AS, Dennis KE, Goldberg AP. Gender differences in the response of plasma leptin concentrations to weight loss in obese older individuals. 1997;5(1):62–68.

  53. Fuente-Martín E, Argente-Arizón P, Ros P, et al. Sex differences in adipose tissue: it is not only a question of quantity and distribution. Adipocyte. 2013;2(3):128–34.

    Article  PubMed  PubMed Central  Google Scholar 

  54. Williams KV, Mullen ML, Kelley DE, Wing RRJDc. The effect of short periods of caloric restriction on weight loss and glycemic control in type 2 diabetes. 1998;21(1):2–8.

  55. Truby H, Baic S, DeLooy A, Fox KR, Livingstone MBE, Logan CM, et al. Randomised controlled trial of four commercial weight loss programmes in the UK: initial findings from the BBC “diet trials”. 2006;332(7553):1309–14.

  56. Cleland C, Ferguson S, Ellis G, et al. Validity of the International Physical Activity Questionnaire (IPAQ) for assessing moderate-to-vigorous physical activity and sedentary behaviour of older adults in the United Kingdom. BMC Med Res Methodol. 2018;18(1):176.

    Article  PubMed  PubMed Central  Google Scholar 

  57. Motl RW, Sasaki JE, Cederberg KL, et al. Validity of sitting time scores from the International Physical Activity Questionnaire-Short Form in multiple sclerosis. Rehabil Psychol. 2019;64(4):463–8.

    Article  PubMed  PubMed Central  Google Scholar 

  58. Dyrstad SM, Hansen BH, Holme IM, et al. Comparison of self-reported versus accelerometer-measured physical activity. Med Sci Sports Exerc. 2014;46(1):99–106.

    Article  PubMed  Google Scholar 

  59. Yang YJ, Kim MK, Hwang SH, et al. Relative validities of 3-day food records and the food frequency questionnaire. Nutr Res Pract. 2010;4(2):142–8.

    Article  PubMed  PubMed Central  Google Scholar 

  60. Jeon KJ, Lee O, Kim H-K, et al. Comparison of the dietary intake and clinical characteristics of obese and normal weight adults. Nutr Res Pract. 2011;5(4):329–36.

    Article  PubMed  PubMed Central  Google Scholar 

  61. Kalra S, Kalra P. NPY: a novel on/off switch for control of appetite and reproduction. Neuropeptide Y and related peptides: Springer; 2004. p. 221–49.

  62. Sirotkin AV, Rafay J, Kotwica J, et al. Role of ghrelin in regulating rabbit ovarian function and the response to LH and IGF-I. Domest Anim Endocrinol. 2009;36(3):162–72.

    Article  CAS  PubMed  Google Scholar 

  63. Sirotkin AV, Rafay J, Kotwica J. Leptin controls rabbit ovarian function in vivo and in vitro: possible interrelationships with ghrelin. Theriogenology. 2009;72(6):765–72.

    Article  CAS  PubMed  Google Scholar 

  64. Pulido JME, Salazar MA. Changes in insulin sensitivity, secretion and glucose effectiveness during menstrual cycle. Arch Med Res. 1999;30(1):19–22.

    Article  CAS  Google Scholar 

  65. Dafopoulos K, Chalvatzas N, Kosmas G, et al. The effect of estrogens on plasma ghrelin concentrations in women. J Endocrinol Investig. 2010;33(2):109–12.

    Article  CAS  Google Scholar 

  66. Yki-Järvinen H. Insulin sensitivity during the menstrual cycle. J Clin Endocrinol Metab. 1984;59(2):350–3.

    Article  PubMed  Google Scholar 

Download references

Funding

The study was approved and financially supported by Ahvaz Jundishapur University of Medical Sciences (project number NRC-9806).

Author information

Authors and Affiliations

Authors

Contributions

The authors’ responsibilities were as follows—AZ and SAH: conceived and designed the experiments; MS and AZ: wrote the paper; MS and AM: performed the experiments; KAA: analyzed the data; AZ had primary responsibility for the final content.

Corresponding author

Correspondence to Ahmad Zare Javid.

Ethics declarations

Conflict of Interest

The authors declare that they have no conflict of interest.

Ethical Approval

All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.

All procedures were reviewed and approved by the ethics committee of Ahvaz Jundishapur University of Medical Sciences and was registered on the Iranian Registry of Clinical Trials website; IRCT registration no. IRCT20190717044244N1, accessed at https://www.irct.ir/trial/40881.

Informed Consent

Informed consent was obtained from all individual participants included in the study.

Additional information

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Electronic supplementary material

ESM 1

(DOCX 15.7 kb)

Rights and permissions

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Sadeghian, M., Hosseini, S.A., Zare Javid, A. et al. Effect of Fasting-Mimicking Diet or Continuous Energy Restriction on Weight Loss, Body Composition, and Appetite-Regulating Hormones Among Metabolically Healthy Women with Obesity: a Randomized Controlled, Parallel Trial. OBES SURG 31, 2030–2039 (2021). https://doi.org/10.1007/s11695-020-05202-y

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11695-020-05202-y

Keywords

  • Appetite
  • Continuous energy restriction
  • Fasting-mimicking diet
  • Weight loss